The depletion of FAM189A2 in breast cancer cells prohibits the CXCL12‐stimulated endocytosis of CXCR4 and, importantly, enhances the cellular function of CXCR4 for the cell migration and stemness. This evidence concerns the gene CXCL12 and breast cancer.